Table 1.
Baseline characteristics of I-ELCAP participants in New York State who died of GI cancer. Notably, there were significantly more men than women. The mean pack-years was high (> 50 pack-years), and the mean age at death was 75.9 years.
| All GI cancers (n = 189) (%) |
Pancreas n = 79 (%) |
Esophagus n = 33 (%) |
Colon n = 32 (%) |
Liver n = 18 (%) |
Gastric n = 16 (%) |
Bile duct carcinoma n = 6 (%) |
Rectum n = 4 (%) | Gallbladder n = 1 (%) |
P-value | |
|---|---|---|---|---|---|---|---|---|---|---|
|
Age at baseline Mean (standard deviation) |
67.1 (6.20) | 66.9 (6.74) | 67.3 (4.83) |
66.6 (5.10) |
66.9 (7.43) |
69.2 (7.17) |
67.0 (7.27) |
64.5 (3.11) |
72.0 (-) |
0.83 |
|
Age at deaths Mean (standard deviation) |
75.9 (7.36) | 75.0 (7.88) | 76.2 (7.10) | 75.8 (6.55) | 75.4 (6.62) | 79.6 (6.69) | 78.7 (9.67) | 74.0 (7.62) | 78.0 (-) | 0.41 |
| Female | 72 (38) | 33 (41.3) | 5 (15) | 18 (56) | 6 (33) | 3 (19) | 2 (33) | 4 (100) | 1 (100) | < 0.05 |
| Male | 117 (62) | 46 (57.5) | 28 (85) | 14 (44) | 12 (67) | 13 (81) | 4 (67) | 0 (0) | 0 (0) | |
|
Race African American/ West Indian |
16 (8.6) | 5 (6.3) | 3 (9.1) | 4 (13) | 3 (17) | 1 (6.7) | 0 (0) | 0 (0) | 0 (0) | 0.56 |
| Asian | 3 (1.6) | 1 (1.3) | 1 (3) | 0 (0) | 1 (5.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Spanish/ Hispanic/ Latino | 3 (1.6) | 1 (1.3) | 0 (0) | 1 (3.2) | 0 (0) | 0 (0) | 0 (0) | 1 (25) | 0 (0) | |
| Caucasian | 163 (88) | 70 (87.5) | 29 (88) | 26 (84) | 14 (78) | 14 (93) | 6 (100) | 3 (75) | 1 (100) | |
| Patient reported comorbidity | ||||||||||
| Diabetes | 12 (6.3) | 8 (10) | 1 (3) | 1 (3.1) | 2 (11) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.64 |
| Asthma | 14 (7.4) | 73 (91.3) | 33 (100) | 27 (84) | 17 (94) | 16 (100) | 4 (67) | 4 (100) | 1 (100) | 0.07 |
| Emphysema or COPD | 30 (16) | 16 (20) | 5 (15) | 2 (6.2) | 3 (17) | 3 (19) | 1 (17) | 0 (0) | 0 (0) | 0.70 |
| High Cholesterol | 7 (3.7) | 3 (3.8) | 1 (3) | 1 (3.1) | 0 (0) | 1 (6.2) | 0 (0) | 1 (25) | 0 (0) | 0.44 |
| Hypertension | 19 (10.1) | 6 (7.5) | 5 (15) | 3 (9.4) | 2 (11) | 2 (12) | 0 (0) | 1 (25) | 0 (0) | 0.71 |
| Peripheral Vascular Disease | 1 (0.5) | 0 (0) | 0 (0) | 1 (3.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.41 |
| Myocardial infarction | 3 (1.6) | 1 (1.3) | 0 (0) | 1 (3.1) | 0 (0) | 0 (0) | 1 (17) | 0 (0) | 0 (0) | 0.24 |
| Stroke | 6 (3.2) | 3 (3.8) | 1 (3) | 2 (6.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.90 |
| Liver disease | 1 (0.5) | 0 (0) | 0 (0) | 1 (3.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.41 |
| Other cancer | 5 (2.6) | 2 (2.5) | 2 (6.1) | 0 (0) | 0 (0) | 1 (6.2) | 0 (0) | 0 (0) | 0 (0) | 0.59 |
| Smokers/ Current | 187 (99)/ 94 (52) | 77 (97) / 36 (49) | 33 (100)/ 14 (44) | 32 (100)/ 18 (56) | 18 (100)/ 12(67) | 16 (100)/ 8(53) | 6 (100)/ 3(50) | 4 (100)/ 3 (75) | 1 (100)/ 0(0) | |
|
Pack-years Mean (standard deviation) |
53.9 (28.5) | 50.0 (24.7) | 58.4 (29.0) | 53.8 (30.2) | 55.6 (22.2) | 59.1 (35.0) | 69.9 (57.6) | 37.5 (22.2) | 60.0 (-) | 0.86 |
| Family history of lung cancer | 26 (14) | 11 (14) | 2 (6.1) | 3 (9.4) | 2 (11) | 4 (25) | 3 (50) | 1 (25) | 0 (0) | 0.12 |